Search Results 1131-1140 of 21718 for Inhibition

1. Study Of Efficacy And Safety Of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With Or Without Ribavirin For Participants With Hepatitis C Genotype 1, 4, Or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

   ... inhibitor [NRTI] backbone of tenofovir or abacavir and either emtricitabine or lamivudine plus raltegravir (or dolutegravir or rilpivirine) (no changes in ...

2. Occipital nerve stimulation: Effective migraine treatment? - Mayo Clinic

   Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Sleep tips: 6 steps to better sleep · Stool color ...

3. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

   Receipt of a strong CYP3A4 inducer within 12 days prior to cycle 1 day 1 or a strong CYP3A4 inhibitor within 7 days prior to cycle 1 day 1 (Table 8) ...

4. A Study in Subjects With Relapsed and Refractory Multiple Myeloma Receiving Carfilzomib in Combination With Dexamethasone, Comparing Once-weekly Versus Twice-weekly Carfilzomib Dosing (ARROW) - Mayo Clinic

   Prior exposure to a proteasome inhibitor (PI); Documented response of at least partial response (PR) to 1 line of prior therapy. Measurable disease with at ...

5. Study Using Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms - Mayo Clinic

   Taking any of the following drugs at the time of study participation: epidermal growth factor receptor inhibitor, topoisomerase 1 inhibitor (camptothecin ...

6. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   Subjects who have received prior treatment with any JAK inhibitors. ... Topical treatments that could affect atopic dermatitis (e.g., corticosteroids, calcineurin ...

7. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

   ... inhibitors including baricitinib, TNF inhibitors, or interferon within 4 weeks or 5 half-lives prior to screening. Steroid dependency defined as need for ...

8. A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of NIO752 in Participants with Progressive Supranuclear Palsy - Mayo Clinic

   agonist, catechol-o-methyltransferase (COMT) inhibitor, rasagiline, CoQ10 or other. Parkinson's medications, acetylcholinesterase inhibitors, antipsychotics, ...

9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   ... inhibitors are permitted. NOTE: Warfarin may not be started while enrolled in ... inhibitor therapy is disallowed; suggested regimens to replace ...

10. Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    Concomitant use of proton pump inhibitors (or unable to stop 5 days prior to treatment); Receipt of live vaccinations within 28 days prior to registration ...